Kap Sum Foong, MD FIDSA

ID physician. Interested in Epidemiology | Infection Control | Diagnostic & Antimicrobial Stewardship. Scuba diver. Retweet≠endorsement

[Open Forum Infectious Diseases @OFIDJournal]

Penicillin Allergy Labels and High-Risk Antibiotic Prescribing Among Incarcerated Individuals Receiving Antibiotics Across Four U.S. Carceral Systems

✅ Just Accepted
🔗 https://t.co/wSWSFgGOLx

[Kap Sum Foong, MD FIDSA @kap_sum]

Our new publication: In four US correctional systems, 10% of incarcerated individuals receiving antibiotics carried a penicillin allergy label, and those labels were associated with >2× odds of high-risk C. difficile–associated antibiotic use.
Read more: https://t.co/5IpAscJZ88

[Clinical Infectious Diseases @CIDJournal]

A Public Health Approach to Antimicrobial Stewardship in Long-Term Care Facilities: A Multifaceted Program in Massachusetts

✅ Just Accepted
🔗 https://t.co/Xvrknb1E1u

[Kap Sum Foong, MD FIDSA @kap_sum]

🚨 Excited to share our new publication in CID! Antimicrobial stewardship in LTC is feasible and scalable when supported by public health infrastructure. A multicomponent approach can shift prescribing toward safer patterns. https://t.co/eHPfI9w6AA

[Kap Sum Foong, MD FIDSA @kap_sum]

Grateful to IDSA for the opportunity to contribute to Science Speaks blog. This piece reflects on implementation challenges and emerging policy opportunities, and what it will take to make penicillin allergy delabeling more accessible, equitable, and scalable.

[IDSA @IDSAInfo]

On IDSA’s & @HIVMA’s Science Speaks blog: @kap_sum explores how proposed legislation can help close gaps by aligning reimbursement, EHR integration and workforce training to make penicillin allergy delabeling routine across all care settings. https://t.co/T1TMkMYTQO

[Kap Sum Foong, MD FIDSA @kap_sum]

Great time at #IDWeek2025!
1️⃣ Reconnecting with friends
2️⃣ Honored to be inducted as a FIDSA alongside one of my favorite WashU seniors
3️⃣ Grateful to present our collaborative work with Massachusetts DPH on the statewide Antibiotic Start Reporting Program in long-term care

[Kap Sum Foong, MD FIDSA @kap_sum]

Thrilled to share our new publication on #penicillinallergy #delabeling practices and barries across SHEA SRN institutions. We found wide variability in practices, with barriers eg limited EHR integration, and lack of outcome tracking.
https://t.co/ZvgglAkc1M

[Kap Sum Foong, MD FIDSA @kap_sum]

Excited to share our Letter to the Editor urging caution on adopting plasma #mNGS for #NHSN #CLABSI surveillance, highlighting why it may not be ready for prime time. Grateful to my co-authors for their insights.

https://t.co/yBljiiBFFx

[Kap Sum Foong, MD FIDSA @kap_sum]

Happy to have contributed to the Clinical Dilemmas in Infectious Diseases series in CID. Grateful for the opportunity to share this challenging case and the lessons it offers for clinical practice.

https://t.co/Cji30JqT6S

[Kap Sum Foong, MD FIDSA @kap_sum]

Honored to be elected a Fellow of the Infectious Diseases Society of America (FIDSA) this year! Grateful for the support and nomination from Drs. Deb Poutsiaka and Shira Doron.
#IDSA
https://t.co/YPh2ykGGI8

[Kap Sum Foong, MD FIDSA @kap_sum]

Excited to share our commentary on #PenicillinAllergy delabeling in long-term care facilities—if not now, then when? We explore gaps, barriers, and actionable solutions for #Delabeling in this vulnerable population! #Geriatrics

https://t.co/OghMx7sxhE

@ShiraDoronMD @IDDoc1978

[Kap Sum Foong, MD FIDSA @kap_sum]

Excited to share our new publication! Our findings show incomplete beta-lactam #allergy documentation increases the risk of prescribing antibiotics most associated with #Cdiff infection in long-term care residents.#delabeling
@ShiraDoronMD @IDDoc1978

https://t.co/lx5EUUOPdY

[Kap Sum Foong, MD FIDSA @kap_sum]

Thank you for the shout-out! https://t.co/6vibsnG5o6

[Kap Sum Foong, MD FIDSA @kap_sum]

2023-2024 LEAP Fellows #IDWeek2024

[Kap Sum Foong, MD FIDSA @kap_sum]

@ASHE_Journal

[Kap Sum Foong, MD FIDSA @kap_sum]

Thrilled to share our latest LEAP work on #penicillin #allergy and beta-lactam use in Massachusetts LTC facilities, offering insights into penicillin allergy #delabeling in this population.
@ShiraDoronMD @IDDoc1978

https://t.co/xFSi8wqTRp

[Kap Sum Foong, MD FIDSA @kap_sum]

Excited to share our latest publication in the Journal of Infection! We explored the IL-6 hypothesis in severe and critical COVID-19 using Sirukumab.

https://t.co/cr2cPmVmjH

[Kap Sum Foong, MD FIDSA @kap_sum]

Thrilled to share our collaborative work with the Masschusetts DPH: Antibiotic Allergy Prevalence and Documentation Quality in Massachusetts Long-Term Care Facilities:A Cross-Sectional Survey
@ShiraDoronMD @IDDoc1978
#antibioticallergy #penicillinallergy
https://t.co/5bm0RBzqMu

[Kap Sum Foong, MD FIDSA @kap_sum]

I’m thrilled and honored to be one of the four recipients of the 2023-24 #LEAPfellowship award from #IDSA. Grateful for the senior mentorship support (@ShiraDoronMD) from #TuftsMC, and Iooking forward to partnering with the Massachusetts Department of Public Health!

[WashU Medicine Division of Infectious Diseases @WashUMedID]

We have unfilled #IDfellowship spots @WUSTLmed If you are interested in ID consider joining us in beautiful St Louis! World class research, friendly collegial environment and the best profession! #IDTwitter #match2022 #MedTwitter